chr11-2571391-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PP3PP5_Very_Strong
The NM_000218.3(KCNQ1):c.671C>T(p.Thr224Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000137 in 1,611,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000048 ( 0 hom. )
Consequence
KCNQ1
NM_000218.3 missense
NM_000218.3 missense
Scores
14
3
2
Clinical Significance
Conservation
PhyloP100: 5.66
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM1
In a helix (size 12) in uniprot entity KCNQ1_HUMAN there are 13 pathogenic changes around while only 0 benign (100%) in NM_000218.3
PP3
MetaRNN computational evidence supports a deleterious effect, 0.775
PP5
Variant 11-2571391-C-T is Pathogenic according to our data. Variant chr11-2571391-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 67096.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-2571391-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.671C>T | p.Thr224Met | missense_variant | 4/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.671C>T | p.Thr224Met | missense_variant | 4/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.290C>T | p.Thr97Met | missense_variant | 4/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.410C>T | p.Thr137Met | missense_variant | 5/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.478-12044C>T | intron_variant | ENSP00000495806 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152124Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
15
AN:
152124
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248566Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134924
GnomAD3 exomes
AF:
AC:
1
AN:
248566
Hom.:
AF XY:
AC XY:
1
AN XY:
134924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1459502Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726174
GnomAD4 exome
AF:
AC:
7
AN:
1459502
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
726174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74282
GnomAD4 genome
AF:
AC:
15
AN:
152124
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74282
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Translational Genomics Laboratory, University of Maryland School of Medicine | Dec 21, 2017 | The c.671C>T variant in codon 224 (exon 5) of the potassium voltage-gated channel subfamily Q member 1 gene, KCNQ1, results in the substitution of Threonine to Methionine. Missense variants in the KCNQ1 gene are known to cause autosomal dominant hereditary long QT syndrome 1 (also known as Romano-Ward syndrome) and autosomal recessive Jervell and Lange-Nielsen syndrome (24667783, 15840476, 27761162). The c.671C>T variant was not observed in the NHLBI Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium databases, however the c.671C>T variant was previously reported in a patient with long QT syndrome (19716085 Multiple lines of computational evidence (MutationTaster, FATHMM, GERP, MetaSVM, MetalR, Provean, LRT, SIFT) predict this variant is probably damaging to the protein structure, function, or protein-protein interaction. The c.671C>T variant is located within a transmembrane region of the protein that has minimal benign variation among individuals in population databases and in the literature (27761162, 17227916). ACMG criteria = PS4, PM1, PM2, PP3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 224 of the KCNQ1 protein (p.Thr224Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with long QT syndrome (PMID: 19841298, 33141630; external communication). It is commonly reported in individuals of Amish ancestry (PMID: 19841298; external communication). ClinVar contains an entry for this variant (Variation ID: 67096). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 33141630). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 18, 2024 | Variant summary: KCNQ1 c.671C>T (p.Thr224Met) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 248566 control chromosomes (gnomAD). c.671C>T has been reported in the literature in individuals affected with Long QT Syndrome (e.g. Mahdieh_2020). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in a loss of channel function (Streeten_2020). The following publications have been ascertained in the context of this evaluation (PMID: 32470535, 33141630). ClinVar contains an entry for this variant (Variation ID: 67096). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2024 | Reported as highly enriched in the Amish (carrier frequency 1/45), likely through a founder effect and genetic drift (PMID: 33141630); Reported in >20 individuals with LQTS, either of Amish lineage or unspecified, however, segregation data were not described and it is unclear how many individuals are from the same kindred (PMID: 19716085, 19841298, 28794082, 34319147); Published functional studies showed that p.(T224M) generates significantly less current than wild type channel; additional studies are warranted to validate the functional effect of this variant in vivo (PMID: 33141630); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22581653, 19841298, 34467620, 34532947, 28794082, 34319147, 34505893, 32470535, 24223155, 33141630, 19716085) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | KCNQ1: PM2, PS3:Moderate, PS4:Moderate, PP4 - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 12, 2023 | The c.671C>T (p.T224M) alteration is located in exon 4 (coding exon 4) of the KCNQ1 gene. This alteration results from a C to T substitution at nucleotide position 671, causing the threonine (T) at amino acid position 224 to be replaced by a methionine (M). Based on data from gnomAD, the T allele has an overall frequency of <0.001% (1/248566) total alleles studied. The highest observed frequency was 0.001% (1/112482) of European (non-Finnish) alleles. This alteration has been detected in individuals with features of long QT syndrome; however clinical details were limited in some cases (Kapplinger, 2009; Roberts, 2017; Schwartz, 2009; Behr, 2013). This alteration has also been reported as an Amish founder mutation associated with a significant increase in QTc interval; however, it does appear to have low penetrance (Streeten, 2020). This alteration has also been reported in a homozygous state in a 6 year old female with prolonged QT and syncope (Mahdieh, 2020). This amino acid position is highly conserved in available vertebrate species. This alteration is located in the extracellular space between the S3 and S4 transmembrane helices. Functional studies suggest this variant may result in a reduction in current; however, these types of studies do not always reflect physiological significance (Streeten, 2020). This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Cardiac arrhythmia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 26, 2023 | This missense variant replaces threonine with methionine at codon 224 of the KCNQ1 protein. This variant is found within the highly conserved extracellular linker region (a.a. 218-225). Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). A functional study has shown that this variant causes a significant reduction in total activating and deactivating currents (PMID: 33141630). This variant has been reported in many individuals affected with long QT syndrome including two young homozygous individuals (PMID: 19716085, 19841298, 32470535, 33141630) and has been reported to segregate with disease in one family (PMID: 19841298). In particular, this variant has been reported to be a common cause of long QT syndrome in the Amish population with 34/88 (38.6%) of carriers versus 3/54 (5.5%) of non-carriers showing clinical evidence of long QT syndrome (P=0.0006) (PMID: 33141630). This study has suggested that the phenotypes associated with this variant appear to be mild. While this variant is observed at 1/45 frequency in the Amish population (PMID: 33141630), it is rare in the general population and has been identified in 1/248566 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;D;.
Vest4
0.95, 0.92
MutPred
0.85
.;Loss of sheet (P = 0.0063);.;
MVP
MPC
1.2
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at